About Us
Mission and History
Corporate Key Facts
Research & Development
Epistemic Drug Discovery
Metabolic Diseases: Type 2 Diabetes
Neuroscience
Oncology
Respiratory Diseases: Asthma & COPD
Proof of Concept Initiative
Pipeline
Discovery Partnerships
Collaborations
News & Publications
News
Publications
Spotlight
About Us
>
Corporate_Key_Facts
Corporate Key Facts
Mission and History
Corporate Key Facts
CORPORATE KEY FACTS
Founded as a spin-off biotech company of the leading scientific information provider
Prous Science
(acquired by Thomson Reuters in 2007)
Headquarters and laboratories located in Barcelona and International Development Offices in US & Japan (planned 2013)
Strong leadership team with track record in industry and academia
Proprietary chemical libraries and proven drug discovery platform (Symmetry®) based on unique in silico technologies
Focused on four main discovery programs:
cancer, pain, diabetes
and
neurodegenerative diseases
with ongoing preclinical projects
Active partnerships with leading academic and regulatory institutions including two five year agreements with the
US Food and Drug Administration
(FDA)
Ongoing
Drug Discovery Partnerships
with Pharma and Biotech organizations
Strong private financial backing to advance internal research programs and investment in emerging opportunities
Research partially funded by publically supported CDTI grants (Center for Industrial Technological Development - Ministry for Science and Innovation)
Associated with The
Barcelona Science Park